Anna Marzá Florensa

76 Chapter 3 control of hypertension in the Southern Cone of Latin America. Am J Hypertens. 2016;29(12):1343–52. 48. Lamelas P, Diaz R, Orlandini A, Avezum A, Oliveira G, Mattos A, et al. Prevalence, awareness, treatment and control of hypertension in rural and urban communities in Latin American countries. J Hypertens. 2019;37(9):1813–21. 49. Bruthans J, Mayer O, De Bacquer D, De Smedt D, Reiner Z, Kotseva K, et al. Educational level and risk profile and risk control in patients with coronary heart disease. Eur J Prev Cardiol. 2016;23(8):881–90. 50. Bansilal S, Castellano JM, Fuster V. Global burden of CVD: Focus on secondary prevention of cardiovascular disease. Int J Cardiol. 2015;201:S1–7. 51. Vynckier P, Kotseva K, Gevaert S, De Bacquer D, De Smedt D. Gender differences in cardiovascular risk factor awareness: Results from the ESC EORP EUROASPIRE V Registry. Int J Cardiol. 2022;352(December 2021):152–7. 52. Marzà-Florensa A, Drotos E, Gulayin P, Grobbee DE, Irazola V, Klipstein-Grobusch K, et al. Prevalence of cardioprotective medication use in coronary heart disease patients in South America: Systematic review and meta-Analysis. Glob Heart. 2022;17(1):37.

RkJQdWJsaXNoZXIy MTk4NDMw